Dietary Supplements Market Size, Growth & Trends Report by 2033 Global Dietary Supplements Market Analysis and Forecast The global dietary supplements market is witnessing robust growth, driven by increasing consumer awareness regarding health and wellness, rising prevalence of lifestyle-related diseases, and a shift toward preventive healthcare. The global dietary supplements market size was valued at USD 194.56 billion in 2024 and is projected to reach from USD 211.68 billion in 2025 to USD 415.63 billion by 2033, growing at a CAGR of 8.80% during the forecast period (2025-2033). View report @ https://straitsresearch.com/report/dietary-supplements-market Market Dynamics 1. Rising Health Consciousness The global population is becoming increasingly health-conscious, leading to greater demand for dietary supplements that support immunity, energy, bone strength, heart health, and mental well-being. The COVID-19 pandemic has significantly reinforced the importance of nutritional support, encouraging daily supplementation among all age groups. 2. Growth in Sports and Fitness Culture The surge in gym memberships, home workouts, and professional athletic training is pushing the demand for protein powders, amino acids, and other sports nutrition supplements. Younger demographics are especially inclined toward supplements that boost performance, endurance, and recovery. 3. Aging Population and Geriatric Nutrition A growing elderly population worldwide is driving the need for supplements that support bone density, joint health, memory, and cardiovascular health. Calcium, vitamin D, omega-3, and multivitamin formulations are seeing increased uptake among this group. 4. Malnutrition and Micronutrient Deficiencies In both developing and developed countries, a significant portion of the population suffers from micronutrient deficiencies. Dietary supplements are a critical tool in addressing deficiencies in iron, vitamin A, folic acid, iodine, and zinc, especially among children and pregnant women. 5. Expansion of E-Commerce and Digital Wellness Platforms The shift toward online retail channels is making dietary supplements more accessible. Consumers are now able to compare products, read reviews, and receive targeted health recommendations, driving market penetration even in rural and semi-urban areas. Request sample report @ https://straitsresearch.com/report/dietary-supplements-market/request-sample Market Segmentation By Type Vitamins Minerals Botanicals (Herbal Extracts) Proteins and Amino Acids Enzymes Fatty Acids (Omega-3, Omega-6) Probiotics and Prebiotics By Form Tablets Capsules Powders Liquids Softgels Gummies By End User Infants Children Adults Pregnant Women Geriatric Population By Distribution Channel Pharmacies and Drug Stores Supermarkets and Hypermarkets Health and Wellness Stores Online Platforms Regional Insights Detail segmentation available @ https://straitsresearch.com/report/dietary-supplements-market/segmentation Asia-Pacific This region dominates the global market and is expected to maintain its lead throughout the forecast period. Factors such as rising disposable income, growing health awareness, rapid urbanization, and the presence of key manufacturing hubs in countries like India, China, and Japan are driving regional growth. North America A mature and high-value market, North America is witnessing sustained demand, particularly in the United States. Factors contributing to growth include widespread awareness of dietary health, a well-established supplement industry, and a strong regulatory framework. Europe Consumer preference for clean-label and organic products is boosting demand for naturally derived supplements. Aging populations in countries like Germany, Italy, and France are also influencing market dynamics. Latin America, Middle East, and Africa These emerging markets are experiencing steady growth due to improving healthcare infrastructure, rising disposable income, and greater awareness of nutritional needs. Trends Shaping the Market Personalized Nutrition There is a noticeable shift toward personalized supplement plans based on individual genetics, dietary habits, and health goals. Companies are introducing AI-based apps and diagnostic kits to deliver customized vitamin and nutrient solutions. Clean Label and Organic Products Consumers are seeking supplements made from natural, non-GMO, gluten-free, and vegan-friendly ingredients. Labels that emphasize transparency, sustainability, and ethical sourcing are gaining traction. Convenience Formats The market is experiencing growth in easy-to-consume formats such as gummies, dissolvable strips, and chewables. These formats are especially popular among children and older adults. Immunity-Boosting Formulations Post-pandemic health awareness has led to sustained demand for supplements that support immune function, such as vitamin C, vitamin D, zinc, echinacea, and elderberry. Key Players in the Market The dietary supplements industry is highly competitive and fragmented. Several global and regional players are actively involved in product development, partnerships, and market expansion. Key companies include: Amway Bayer AG Nestlé Health Science Abbott Laboratories Glanbia PLC Pfizer Inc. Herbalife Nutrition GSK Consumer Healthcare Arkopharma Danone Himalaya Wellness BASF SE Archer Daniels Midland Company These companies are investing in R&D, e-commerce expansion, and sustainable sourcing to strengthen their market position. Future Outlook The dietary supplements market is expected to continue its upward trajectory, driven by technological innovation, expanding middle-class populations in emerging economies, and the global push for preventive health solutions. Categories such as immunity boosters, brain health supplements, and anti-aging products are poised for significant growth. As regulatory frameworks mature and consumer trust increases, the industry will see further consolidation and innovation. Having query ask @ https://straitsresearch.com/buy-now/dietary-supplements-market Conclusion The global dietary supplements market presents vast opportunities across product categories, regions, and consumer segments. With a projected value exceeding USD 415 billion by 2033, the sector is becoming a cornerstone of global health and wellness. Brands that prioritize transparency, innovation, personalization, and accessibility are best positioned to capitalize on this dynamic market landscape. About Us StraitsResearch.com is a leading research and intelligence organization, specializing in research, analytics, and advisory services. We provide comprehensive business insights and research reports to empower strategic decision-making across industries. Contact Us: Email: sales@straitsresearch.com Website: https://straitsresearch.com

Hepatitis B Treatment Market to Surpass USD 7.3 Billion by 2032 The global Hepatitis B Treatment Market is positioned for consistent growth, with market valuation expected to increase from USD 4.5 billion in 2023 to USD 7.3 billion by 2032, growing at a CAGR of 5.9% during the forecast period (2024–2032). The rise in chronic hepatitis B cases globally, combined with growing awareness, treatment accessibility, and a strong pipeline of advanced therapies, is propelling the market forward. Key Market Drivers Rising Global Burden of Hepatitis B An estimated 296 million people worldwide are living with chronic hepatitis B infection. Despite the availability of effective vaccines, millions remain undiagnosed and untreated, particularly in low- and middle-income countries. This presents a significant opportunity for therapeutic expansion. Therapeutic Advancements and Pipeline Innovation Existing therapies such as nucleos(t)ide analogs (tenofovir and entecavir) dominate the market, but recent developments are shifting focus toward functional cures. The next wave of treatment includes capsid assembly modulators, RNA interference therapies, therapeutic vaccines, and immune-based agents designed to achieve long-term viral suppression and surface antigen clearance. Increasing Awareness and Government Screening Initiatives Governments around the world are implementing widespread screening and awareness campaigns, particularly in regions with a high disease burden such as Asia-Pacific and Sub-Saharan Africa. Early detection initiatives are helping link more patients to long-term treatment, increasing market demand. Strategic Collaborations and Regulatory Support Pharmaceutical companies are forming strategic partnerships with research institutions and health agencies to accelerate the development of novel therapies. Regulatory bodies are also fast-tracking approvals for promising candidates, which is expediting market entry and encouraging R&D investment. Accessibility and Affordability in Emerging Markets The introduction of cost-effective generic drugs and public-private partnerships are enabling broader access to hepatitis B treatment in resource-constrained settings. This trend is expected to significantly impact volume growth in developing countries. Download Sample Report: https://www.datamintelligence.com/download-sample/hepatitis-b-treatment-market?u  Market Segmentation By Drug Class: Nucleos(t)ide Analogues: This category leads the market with drugs like tenofovir disoproxil fumarate, tenofovir alafenamide, and entecavir. These agents are well-established for viral suppression and are widely recommended in clinical guidelines. Immune Modulators: Agents such as pegylated interferon-alpha are prescribed for finite-duration treatment and are gaining renewed attention when combined with new pipeline agents aiming for a cure. Pipeline Drugs: Emerging candidates like siRNA-based therapies, capsid inhibitors, and therapeutic vaccines are being developed for long-term efficacy and reduced resistance. Several are in advanced clinical stages and could enter the market within the next 3–5 years. By Type: Chronic Hepatitis B: The chronic segment dominates the market due to its high prevalence and need for long-term treatment. Acute Hepatitis B: This segment accounts for a smaller share, as many acute infections resolve spontaneously. However, the need for monitoring and potential early treatment still drives demand. By Distribution Channel: Hospital Pharmacies: Major revenue contributor, especially in countries where treatment initiation is done under specialist supervision. Retail Pharmacies: Widely used for continued outpatient therapy and access to generic drugs. Online Pharmacies: Growing segment with improved logistics and digital health adoption, particularly post-pandemic. Request a customized report tailored to your business needs: https://www.datamintelligence.com/customize/hepatitis-b-treatment-market?u  Regional Insights Asia-Pacific: This region holds the largest market share, driven by the high incidence of HBV infections in China, India, and Southeast Asia. Government initiatives and improved healthcare infrastructure are increasing diagnosis and treatment rates. North America: Strong presence of major pharmaceutical players and access to advanced therapies contribute to high per-patient spending. The U.S. market benefits from favorable reimbursement and steady R&D investment. Europe: Countries like Germany, France, and the UK are advancing their public health efforts and expanding national hepatitis strategies. The presence of well-established regulatory pathways aids in new product launches. Latin America and Middle East & Africa: These are emerging markets with increasing investment in healthcare infrastructure and improved access through global health programs. Recent Industry Trends Therapeutic vaccines and gene-silencing approaches are leading the race toward achieving a functional cure. Combination therapies combining antivirals with immune modulators are in advanced trial phases. Biopharma companies are investing heavily in hepatitis B R&D, and several collaborative ventures have been announced globally in the past 12 months. Focus is shifting from suppression to eradication of surface antigen (HBsAg), considered a critical marker for long-term remission. Generic penetration is improving access in Africa and Southeast Asia, while branded innovation is driving revenue in developed markets. Buy an Exclusive copy of this Report: https://www.datamintelligence.com/buy-now-page?report=hepatitis-b-treatment-market?u Challenges Facing the Market Long-Term Therapy and Adherence Issues Patients with chronic hepatitis B require continuous therapy, often for life. Ensuring adherence remains a challenge, particularly in rural or underserved areas. Side Effects and Resistance Although existing drugs are effective, some patients experience drug resistance or adverse effects over prolonged use, necessitating new safer alternatives. Stigma and Lack of Awareness Social stigma and misinformation in many regions lead to underdiagnosis and poor treatment uptake. This underscores the need for broader public education campaigns. High Cost of Next-Gen Therapies Advanced treatments under development may enter the market at high prices, creating affordability issues, especially where generics are the norm. Strategic Recommendations for Stakeholders Accelerate Development of Functional Cure Regimens by prioritizing combination therapies and immunotherapies in clinical pipelines. Expand Screening and Vaccination campaigns to identify untreated cases and prevent future infections. Partner with Governments and NGOs to create sustainable access programs, especially in low-income markets. Invest in Education and Digital Outreach to reduce stigma, improve awareness, and support treatment adherence. Monitor Post-Marketing Safety and Resistance Patterns to ensure long-term success of approved products. Subscribe for more Industry reports: https://www.datamintelligence.com/reports-subscription About Us: DataM Intelligence is a market research and consulting firm that provides end-to-end business solutions to organizations, from research to consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology. Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries, catering to the key business research needs that influence the growth trajectory of our vast clientele. Contact Us: Company Name: DataM Intelligence Contact Person: Sai Kiran Email: sai.k@datamintelligence.com Phone: +1 877 441 4866 Website: https://www.datamintelligence.com

Feed Innovation and Biosecurity Drive Global Aquaculture Additive Demand The global aquaculture additives market is experiencing substantial growth, driven by increasing demand for sustainable seafood, innovation in feed technology, and the growing need for efficient disease control in aquaculture systems. The market was valued at USD 4.2 billion in 2024 and is projected to reach USD 7.8 billion by 2033, expanding at a compound annual growth rate (CAGR) of 8.1% between 2026 and 2033. Further projections show a base value of USD 1.11 billion in 2023, expected to grow at 4.2% CAGR from 2024 to 2032. Other estimates place the market at USD 2.2 billion in 2023, projected to reach USD 3.1 billion by 2030, reflecting a CAGR of 4.3% between 2024 and 2030. The varying figures highlight the segment’s broad definition, ranging from complete feed additives to species-specific nutritional solutions. Key Market Drivers & Growth Catalysts Rising Global Seafood Consumption As global populations and health consciousness rise, seafood demand is surging. Aquaculture now accounts for over 50% of all seafood consumed, prompting investments in performance-enhancing feed additives to increase yield and profitability. Feed Innovation & Functional Additives Technologies are evolving rapidly in the feed segment. Key innovations include probiotics, prebiotics, enzymes, amino acids, vitamins, antioxidants, and natural plant- or marine-based extracts that improve digestion, disease resistance, and feed efficiency. Sustainable & Eco-Friendly Alternatives Growing consumer demand for natural and chemical-free products has pushed producers to shift toward environmentally responsible additives. Algae-based proteins, essential oils, fermented ingredients, and biodegradable solutions are gaining traction. Biosecurity and Disease Control Additives that improve immunity and gut health—like probiotics and immune boosters—are increasingly used to minimize the need for antibiotics and chemical treatments, helping ensure healthier aquaculture ecosystems. Regulatory Incentives and Private Investment Governments and the private sector are investing heavily in aquaculture infrastructure, R&D, and compliance protocols. This includes tax breaks, subsidies, and feed certification programs that encourage adoption of high-quality, sustainable additives. Shift Toward Alternative Proteins Plant, insect, and microbial protein sources are being explored to reduce reliance on traditional fishmeal and soy. Additives that enhance nutrient availability in these alternatives play a critical role in optimizing feed conversion ratios. Download Sample Report: https://www.datamintelligence.com/download-sample/aquaculture-additives-market?u  Regional Overview Asia-Pacific: The region holds the largest market share and is the fastest-growing segment, with a projected CAGR of 7.2% through 2033. Countries like China, India, Indonesia, and Vietnam lead due to large aquaculture bases and favorable government initiatives. North America: Driven by consumer demand for traceable, sustainable seafood and strict food safety standards, the market in this region is growing at a healthy 6.0–6.5% CAGR. Europe: A mature and highly regulated market, Europe sees strong demand for organic and eco-certified aquafeed products, with Norway, Spain, and the UK as major contributors. Latin America and MEA: These are emerging markets with increasing fish farming activity and rising awareness of additive benefits, offering growth opportunities through education and technological transfer. Market Segmentation Insights By Product Type: The aquaculture additives market includes: Amino acids Vitamins Enzymes Probiotics, enzymes, and amino acids are expected to see the highest growth due to their proven role in improving feed digestibility and immune strength. By Application: Additives are used across various species, including Crustaceans Mollusks Carp The demand for species-specific additives is increasing, especially in high-value segments like salmon and shrimp farming. By Form: Additives are typically supplied in powder, liquid, or granulated form. Water-soluble and microencapsulated forms are emerging to improve absorption and minimize waste. By End Use: Complete aqua feed manufacturers Supplement providers Direct-to-farm additive suppliers Ask for the Customized Report as per Your Business Requirements: https://www.datamintelligence.com/customize/aquaculture-additives-market?u  Recent Industry Highlights In Vietnam, aquafeed production increased from 0.673 million tons in January to 0.705 million tons in February 2025, reflecting a 15.6% monthly rise, signaling strong additive demand. The use of spirulina and microalgae as part of additive blends has shown 20% faster shrimp growth at just 5% feed inclusion, indicating performance advantages of functional ingredients. In the United States, feed producers are adopting traceable, antibiotic-free additive strategies to meet eco-certification standards. Japan is exploring precision aquaculture with an emphasis on AI-integrated feed monitoring and traceability, preparing for a surge in premium seafood exports. Buy an Exclusive copy of this Report: https://www.datamintelligence.com/buy-now-page?report=aquaculture-additives-market?u Challenges Regulatory Complexity: Different regions have distinct standards for permissible additive use, requiring manufacturers to tailor formulations for compliance. Price Volatility: Fluctuations in input costs, especially for marine-based proteins and plant extracts, impact overall pricing and margins. Low Awareness in Emerging Markets: Many small-scale fish farmers are unaware of additive benefits or lack training on proper usage, which can limit market penetration. Environmental Concerns: Improper use or overuse of certain additives may lead to waste discharge or ecological imbalance, prompting demand for sustainable, residue-free solutions. Strategic Recommendations for Stakeholders Invest in R&D for functional additives. Develop advanced prebiotics, probiotics, and enzyme-based solutions that support health, improve FCR, and align with regulatory expectations. Focus on Education & Training Deploy farmer education programs to enhance adoption in emerging markets, focusing on dosage, application, and ROI. Enhance Digital Integration Leverage IoT and AI to optimize additive delivery, improve real-time monitoring, and align feed inputs with species needs. Expand Distribution Channels Use B2B platforms, aquaculture cooperatives, and microfinancing models to increase reach in rural or underserved regions. Build Partnerships with Regulators & NGOs Collaborate on sustainability certification programs and co-develop frameworks that encourage natural additive use and discourage over-reliance on antibiotics. Subscribe for more Industry reports: https://www.datamintelligence.com/reports-subscription About Us: DataM Intelligence is a market research and consulting firm that provides end-to-end business solutions to organizations, from research to consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology. Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries, catering to the key business research needs that influence the growth trajectory of our vast clientele. Contact Us: Company Name: DataM Intelligence Contact Person: Sai Kiran Email: sai.k@datamintelligence.com Phone: +1 877 441 4866 Website: https://www.datamintelligence.com

Download Sample Report: https://www.datamintelligence.com/download-sample/veterinary-vaccines-market  The global veterinary vaccines market is entering a phase of sustained growth and innovation, with mounting demand from both companion animal and livestock sectors. According to recent data, market valuation reached USD 12.05 billion in 2024 and is forecast to climb to USD 12.51 billion in 2025 and USD 18.56 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.8%. Meanwhile, additional analysis projects consistent momentum through 2029 with a CAGR between 6.0% and 6.1%, targeting USD 13.33 billion by 2029. As pet ownership skyrockets globally and livestock production intensifies, both segments offer compelling growth opportunities. North America led with a 45.4% market share in 2024, while Asia-Pacific is emerging as the fastest-growing region. Sub-Saharan, Latin American, and Middle Eastern markets are also gaining traction, with the Middle East projected to reach USD 678 million by 2025, expanding to over USD 1 billion by 2035 at a 4% CAGR. Key Market Drivers & Growth Opportunities Surge in Pet and Livestock Ownership – In the United States, 67–70% of households own pets, translating to over 86 million homes. – Europe’s dog and cat population exceeds 66.8 million and 77.9 million, respectively. – India has an estimated 62 million community dogs, with pet dogs projected to reach 31 million by the end of 2023. This rise in ownership fuels demand for companion animal vaccines to prevent diseases such as rabies, distemper, and parvovirus. Heightened Zoonotic Disease Awareness & One Health Strategies – Outbreaks like avian influenza, brucellosis, and rabies highlight the need for cross-species disease prevention. – Agricultural vaccine mandates in Asia-Pacific and mass dog vaccination campaigns (in regions like India and Bangladesh) reinforce One Health principles. Government Programs & Incentive Schemes – The USDA has earmarked up to USD 100 million for poultry flu vaccine research and is preparing a national rollout by July 2025, following losses of over 175 million poultry since 2022. – In India, new approvals like the calf vaccine “BIOLUMPIVAXIN” show growing regulatory support. – Indonesia and other emerging economies are also ramping up livestock immunization initiatives. Technological Breakthroughs in Vaccine Innovation – The release of trivalent poultry vaccines in early 2025 represents the rise of multi-targeted solutions. – DNA, recombinant, viral-vector, nanoparticle, and AI-driven vaccines are being developed for better efficacy and safety. – AI tools are expediting antigen identification, immune modeling, and vaccine design—reducing dependency on prolonged animal trials. Improved Chain & Distribution Infrastructure – Advanced cold storage and IoT monitoring systems are improving reach into remote and rural regions, lowering vaccine wastage and ensuring timely administration. Market Segmentation & Trends By Species: Livestock vaccines accounted for the largest share (~55–60%) due to increasing emphasis on food safety and productivity. – Companion animal vaccines are gaining traction due to rising pet healthcare awareness and adoption of pet insurance. By Technology: – Inactivated vaccines held the leading market share in 2024 (~32.5%), favored for their stability and low virulence. – Live attenuated and DNA vaccines are advancing, supported by strong R&D investment. By Administration Route: – Intramuscular injections dominate the market due to consistent immune response outcomes, followed by subcutaneous injections. – New oral and intranasal vaccine formats are also under evaluation. By region, North America remains dominant with 45.4% market share. Asia-Pacific is the fastest growing due to population dynamics, rising pet ownership, and expanding livestock production. – The Middle East market, valued at USD 678 million in 2025, is projected to cross USD 1 billion by 2035. Ask for the Customized Report as per Your Business Requirements: https://www.datamintelligence.com/customize/veterinary-vaccines-market  Latest Industry Highlights & Regional News United States – The USDA is set to roll out a nationwide poultry vaccination plan by July 2025, backed by USD 100 million in funding, aiming to counter the most severe avian flu outbreak on record. – Novel vaccine approvals for species like honeybees and the deployment of mobile biosecurity tools like RABapp are transforming field diagnostics and response time. – Approximately 47% of U.S. commercial swine farms are now connected via such AI-enabled disease prevention platforms. Japan – Japan is steadily modernizing veterinary infrastructure, emphasizing high-biosecurity environments and advanced diagnostics. – Demand for companion animal vaccines continues to grow, supported by a well-developed pet care sector. With strong domestic biotech R&D capabilities, Japan is poised to adopt next-generation recombinant and mRNA-based veterinary vaccines over the next few years. Buy an Exclusive copy of this Report: https://www.datamintelligence.com/buy-now-page?report=veterinary-vaccines-market  Challenges & Restraints High R&D and Production Costs – Vaccine development can require USD 200–500 million, with an additional USD 50–700 million for multi-antigen production infrastructure. – Cold-chain logistics account for more than 70% of total storage and handling expenses, posing challenges in cost-sensitive regions. Veterinary Workforce Shortages & Vaccine Hesitancy – Emerging markets continue to face deficits in skilled veterinarians and trained livestock workers. – Lack of awareness and trust among rural communities leads to inconsistent vaccine compliance. Export Market Sensitivities – Poultry exporters in North America express concern that vaccination might mask underlying disease presence, affecting trade access to certain countries. – Striking a balance between national disease control and international trade policies remains a key regulatory challenge. Strategic Outlook for Industry Stakeholders Invest in Advanced Vaccine Platforms Embrace DNA, nanoparticle, AI-assisted, and multivalent vaccines for broader immunogenicity and streamlined development. Expand Cold-Chain Capabilities Deploy smart cold-storage infrastructure, especially in rural or underserved regions, to minimize spoilage and delivery delays. Strengthen Public–Private Partnerships Collaborate with governments to align vaccine policy, rollout strategies, and trade implications—especially in the livestock sector. Enhance Awareness and Veterinary Training Capacity-building in emerging markets is critical to expanding vaccine penetration and reducing zoonotic outbreaks. Unlock Untapped Regional Markets Focus on regions like Africa, Southeast Asia, and the Middle East with localized, culturally appropriate vaccine solutions. Subscribe for more Industry reports: https://www.datamintelligence.com/reports-subscription About Us: DataM Intelligence is a market research and consulting firm that provides end-to-end business solutions to organizations, from research to consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology. Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries, catering to the key business research needs that influence the growth trajectory of our vast clientele. Contact Us: Company Name: DataM Intelligence Contact Person: Sai Kiran Email: sai.k@datamintelligence.com Phone: +1 877 441 4866 Website: https://www.datamintelligence.com

Increasing Construction of Skyscrapers Propelling Geotechnical Instrumentation and Monitoring Market Expansion From $3.1 billion in 2018, the geotechnical instrumentation and monitoring market is predicted to reach a revenue of $6.1 billion by 2024. According to the forecast of the market research organization, P&S Intelligence, the market will progress at a CAGR of 11.8% from 2019 to 2024. The market is being driven by the booming construction sector all over the world. Additionally, the increasing focus of the governments of several countries on developing sustainable infrastructure and rapid urbanization are also driving the growth of the market. With rapid urbanization, the number of infrastructural development projects is rising. Moreover, many countries are making huge investments in these projects in order to cater to the needs of a booming population. For instance, an overall investment of $11 trillion was made in the global construction industry in 2017, and this is predicted to rise to $13.5 trillion by the end of 2024. The expansion of the construction industry is being propelled by the surging number of infrastructural development projects in countries, such as the U.S., India, and China. Besides, the construction of skyscrapers in several countries, on account of the growing migration of people from rural areas to cities and rapid urbanization, is also fueling the growth of the geotechnical instrumentation and monitoring market. This is because geotechnical instruments are needed in the planning phase of skyscrapers in order to determine the specifics regarding the foundation of these structures. According to various reports, around 55% of the global population resided in urban areas in 2018, and this share is predicted to rise to 68% by 2030. Depending on component, the market is divided into services, software, and hardware. Out of these, the services category held the largest share in the market in the past, and it is predicted to contribute the highest revenue to the market in the upcoming years as well. This is credited to the burgeoning requirement for these services for continuously monitoring critical structures in the energy and power sector. Additionally, the rising focus on monitoring old and critical structures, such as dams, because of the implementation of strict safety regulations by several governments, is also positively impacting the growth of the industry. Across the world, the Asia-Pacific (APAC) region is predicted to be the fastest-growing region in the geotechnical instrumentation and monitoring market in the coming years. This is attributed to the surging number of infrastructural development projects in regional countries, such as India and China. Moreover, China is making huge investments for countering the effects of the economic slowdown. For instance, the Chinese government has given approval to 27 projects and invested $219.4 billion in these projects since 2018. Therefore, it is safe to say that the demand for geotechnical instrumentation and monitoring services will surge in the coming years, primarily because of the increasing number of construction and infrastructural development projects in various countries around the world. Read More: https://www.psmarketresearch.com/market-analysis/geotechnical-instrumentation-and-monitoring-market

Smart Card IC Market Will Reach USD 4,929.8 Million by 2030 The global smart card IC market will touch USD 4,929.8 million, propelling at a 7.1% compound annual growth rate, by 2030. This is mainly because of the growing utilization of financial cards and other safe payment solutions. Moreover, the acceptance of smart IDs in educational organizations and e-governance projects are propelling growth. The growing need for safe payment solutions is one of the major reasons because of why the industry is rising at a high pace. As the count of e-commerce payments is growing, so is the count of scams and frauds. To dodge being a victim of such scams, more-safe solutions are needed, and smart cards are one such solution, as they provide more safety and privacy than other financial data storage or payment solutions. In 2022, based on end users, the telecommunications category dominated the industry with the largest share. This is mainly because of the use of integrated circuits in subscriber identity modules, boosted by the increasing smartphone acceptance. Businesses are not only offering postpaid and prepaid SIMs but also pay-as-you-go variants with minimal paperwork, which makes it simpler for customers to use such cards. Additionally, numerous steps are being taken by the government of several nations to connect individuals in rural areas with the internet or smartphones. Based on the interface segment, the contactless category is rising at a high pace. This is because of the growing utilization of such cards in several establishments and educational organizations as an access control device. They are utilized in biometric arrangements as they convey information in only one way and do not need the Internet to process. Furthermore, because of the COVID-19 epidemic, several establishments shifted to contactless smart cards, as they are a more-sterile choice over touch-based biometric technologies, like fingerprint and palm geometry recognition. During the forecast period, the APAC region is projected to grow at a high rate, mainly because of the rapid industrialization and urbanization in the region. Moreover, the fast acceptance of novel technologies in the healthcare, telecommunications, and BFSI industries is boosting the addition of integrated circuits in smart cards. Furthermore, the count of SIMs being utilized in the region is growing at a high rate, which will drive the industry’s development. Based on type, in 2022, the microcontroller category led the market with the largest share, and the category is also projected to dominate the market in the future as well, as such chips provide better memory storage and safety to information compared to the old-style magnetic-stripe cards. Hence, the growing utilization of financial cards and other safe payment solutions. Moreover, the acceptance of smart IDs in educational organizations and e-governance projects are the major factors propelling the market. Read More: https://www.psmarketresearch.com/market-analysis/smart-card-ic-market